{
  "actions": [
    {
      "acted_at": "2020-05-19",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2020-05-19",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2020-05-19",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr6930-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "C001090",
      "district": "8",
      "name": "Cartwright, Matt",
      "original_cosponsor": false,
      "sponsored_at": "2020-07-09",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001087",
      "district": "1",
      "name": "Crawford, Eric A. \"Rick\"",
      "original_cosponsor": true,
      "sponsored_at": "2020-05-19",
      "state": "AR",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "G000568",
      "district": "9",
      "name": "Griffith, H. Morgan",
      "original_cosponsor": true,
      "sponsored_at": "2020-05-19",
      "state": "VA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001180",
      "district": "1",
      "name": "McKinley, David B.",
      "original_cosponsor": true,
      "sponsored_at": "2020-05-19",
      "state": "WV",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000597",
      "district": "7",
      "name": "Rice, Tom",
      "original_cosponsor": false,
      "sponsored_at": "2020-10-01",
      "state": "SC",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001200",
      "district": "9",
      "name": "Soto, Darren",
      "original_cosponsor": true,
      "sponsored_at": "2020-05-19",
      "state": "FL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "V000133",
      "district": "2",
      "name": "Van Drew, Jefferson",
      "original_cosponsor": false,
      "sponsored_at": "2020-06-18",
      "state": "NJ",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000821",
      "district": "4",
      "name": "Westerman, Bruce",
      "original_cosponsor": false,
      "sponsored_at": "2020-06-18",
      "state": "AR",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-05-19",
  "number": "6930",
  "official_title": "To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "MADE in America Act of 2020",
  "sponsor": {
    "bioguide_id": "C001103",
    "district": "1",
    "name": "Carter, Earl L. \"Buddy\"",
    "state": "GA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-05-19",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Advanced technology and technological innovations",
    "Buy American requirements",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Foreign and international corporations",
    "Government information and archives",
    "Government studies and investigations",
    "Health",
    "Health technology, devices, supplies",
    "Income tax credits",
    "Income tax deductions",
    "Manufacturing",
    "Prescription drugs",
    "Taxation of foreign income",
    "Technology assessment",
    "Wages and earnings"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2020-05-19",
    "date": "2021-01-28T15:19:36Z",
    "text": "Manufacturing API, Drugs, and Excipients in America Act of 2020 or the MADE in America Act of 2020\n\nThis bill establishes a tax credit for taxpayers engaged in medical production activities in certain areas and contains other provisions related to pharmaceuticals.\n\nAn eligible taxpayer may claim a tax credit equal to 30% of qualified expenditures related to the production of pharmaceuticals, medical devices, or other related items in a designated qualified opportunity zone with a poverty rate higher than 30%.\n\nIn addition, the Food and Drug Administration shall continue a program to evaluate new drug manufacturing technologies included in an application for approval of a drug or biological product. The bill imposes various requirements on this program, including deadlines for evaluating such a technology.\n\nFurthermore, the Department of Health and Human Services shall establish or expand programs to promote regulatory consistency and cooperation with drug regulatory authorities in other countries."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "MADE in America Act of 2020",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "MADE in America Act of 2020",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Manufacturing API, Drugs, and Excipients in America Act of 2020",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:42:52Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr6930.xml"
}